Beckman Coulter Life Sciences presents at ASHG

Beckman Coulter Life Sciences presents at ASHG

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, will feature a full team of dedicated professionals and informative programming at the American Society of Human Genetics (ASHG) Annual Meeting, October 25-29, 2022, in Los Angeles, California, at the Los Angeles Convention Center.

At Booth 2037, attendees will have the opportunity to interact with instrumentation, including one-on-one demonstrations, to learn how to make the Next Generation Sequencing (NGS) workflow a goldsmith for low- to high-throughput laboratories. The NGS market is forecast to reach $22.9 billion by 2025. Therefore, ASHG is an ideal time to learn more about how laboratories can achieve new levels of cost savings and throughput, improve and automate end-to-end NGS automation at standard and reduced reaction volumes, capture current and future workflows, and reliably deliver laboratory results by generating high-quality sequencing data.

With the significant growth of the NGS market, we know that laboratories have many questions and needs for workflow analysis and improvements. Beckman Coulter Life Sciences is uniquely positioned to lead the way with solutions and be a trusted partner in the laboratory. No one wants their research to be ruined by errors or delays. That’s why we’re particularly pleased to be able to deliver solutions that deliver more reliable and accurate lab results with significantly fewer physical steps, allowing the focus to return to the work rather than the workflow.”

Amy Yoder, Director of Genomics Product Management.

The company's entire NGS suite will be on display, including the Biomek NGeniuS Next Generation Library Prep System, the Echo 525 Acoustic Liquid Handler, the Biomek i5 Automated Workstation, as well as NGS purification reagents and the EMnetics system for plasmid preparation and polymerase chain reaction (PCR) purification.

Beckman Coulter Life Sciences will offer two presentations during the event. Biomek NGeniuS Product Manager Calvin Cortes will highlight the revolutionary methodology for accelerating NGS workflows in his talk, “Optimizing your NGS lab with a groundbreaking, easy-to-use automation solution,” taking place on Wednesday, October 26, at 3:00 p.m. PST in the CoLab Theater 3.

Dr. Ryan Wyllie, associate research scientist for biomedical engineering at the University of Michigan, will present on “Improving high-throughput genomics protocols through statistical experimental design.” The presentation is intended to provide clarity as there are a variety of commercial and homegrown methods to reduce the cost or increase the efficiency of genomic testing. Many of these techniques are not optimal when applied to new samples or when the protocol or reagents need to be changed or automated. Re-optimizing a protocol through trial and error is an expensive and laborious process. Systematic frameworks such as statistical design of experiments (DOE) can improve processes by examining the quantitative relationship between multiple factors. DOE allows experimenters to find factor interactions that may not be obvious when factors are examined in isolation. Dr. Wyllie's presentation will take place on Thursday, October 27th at 1:15 pm PST in the CoLab Theater 2.

Both lectures are included in the admission price for the ASHG. For more information about NGS solutions, see https://becls.co/next-generation-sequencing.

Source:

Beckman Coulter Life Sciences

.